Host: Jacqueline Boultwood, University of Oxford
Date and time: Wed 08-Nov-2017, 09:00-11:00
Room: Room 11
Recent advances in genome editing, most notably the advent of CRISPR/Cas9 technology, are revolutionising many areas of cancer research. In this session the speakers will provide an overview of genome editing approaches and discuss the application of these tools to cancer research. Topics covered will include the use of CRISPR/Cas9 gene editing in disease modelling and genome-wide functional screens, with a focus on the identification of therapeutic targets. CRISPR-mediated gene regulation will also feature.
Luigi Naldini, San Raffaele Telethon Institute for Gene Therapy, Italy
George Vassiliou, Wellcome Trust Sanger Institute, UK
Jarno Drost, Princess Máxima Center for Pediatric Oncology, The Netherlands